An emerging pharmaceutical company selected PRA Health Sciences to “rescue” the data management, analysis, database pooling, and integrated summaries from another CRO for an endocrine program comprising 48 studies and 5,500 patients. At the time of rescue, 10 studies were ongoing in Europe and the United States, and data management activities were significantly behind schedule. PRA’s transition effort involved over 100 employees.